First-time EIA publication of Rionlon Pharma's vitamin K2 API preparation and relevant intermediates project

In late Oct., the Environmental Impact Assessment details of "vitamin K2 API preparation and relevant intermediates project", submitted by Rionlon (Tianjin) Pharmaceutical Co., Ltd. (Rionlon Pharma), were publicised for the first time. The company in...

Vitamins China E-News 202211

www.cnchemicals.com